FDA Subcutaneous Injection Site Simulator (SCISSOR)

The FDA's Division of Pharmaceutical Quality Research V (DPQRV) requires a subcutaneous injection site simulator (SCISSOR). The purpose of this solicitation is to obtain a device that can simulate subcutaneous injection sites for research purposes. • The device should be able to mimic the properties of human subcutaneous tissue. • The device should be able to withstand multiple injections. • The device should be easy to use and maintain. The FDA has extended the deadline for responses to 8/5/2026 at 2:00 pm CDT. Interested parties should submit their proposals by the deadline to be considered for the contract.